200
Participants
Start Date
June 2, 2017
Primary Completion Date
April 11, 2019
Study Completion Date
July 11, 2019
Cytoflavin® solution
Single drip infusion of 20 ml of Cytoflavin® solution in 200 ml of 0.9%NaCl intravenously once a day
Cytoflavin® enteric-coated tablet
2 tablets, orally, with 100 ml of drinking water, 30 minutes before meals, 2 times a day, with an interval of 8-10 hours (but no later than 18:00).
Placebo solution
Single drip infusion of 20 ml of placebo solution in 200 ml of 0.9%NaCl intravenously once a day
Placebo enteric-coated tablet
2 tablets, orally, with 100 ml of drinking water, 30 minutes before meals, 2 times a day, with an interval of 8-10 hours (but no later than 18:00).
Regional Clinical Hospital № 3, Chelyabinsk
Central Clinical Hospital with a polyclinic of the Office of the President of the Russian Federation, Moscow
Alexandrovskaya City Hospital, Saint Petersburg
City Hospital №15, Saint Petersburg
City Hospital №38 named after N.A. Semashko, Saint Petersburg
City Hospital №40 of the Kurortny District, Saint Petersburg
Hospital for War Veterans, Saint Petersburg
I. P. Pavlov 1st St. Petersburg State Medical University, Saint Petersburg
Military Medical Academy named after S.M. Kirov, Saint Petersburg
Pokrovskaya City Hospital, Saint Petersburg
"GBUZ YAO Regional Clinical Hospital", Yaroslavl
"Research center of specialized types of medical care Ural Institute of Cardiology", Yekaterinburg
Ural State Medical University, Yekaterinburg
POLYSAN Scientific & Technological Pharmaceutical Company
INDUSTRY